Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Buprenorphine to Improve HIV Care Engagement and Outcomes (BRAVO)

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2016 by Oregon Health and Science University
Sponsor:
Collaborators:
Hanoi Medical University
Minneapolis Medical Research Foundation
Information provided by (Responsible Party):
P. Todd Korthuis, Oregon Health and Science University
ClinicalTrials.gov Identifier:
NCT01936857
First received: September 3, 2013
Last updated: May 12, 2016
Last verified: May 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: April 2018
  Estimated Primary Completion Date: April 2018 (Final data collection date for primary outcome measure)